Astrazeneca Pharma India Ltd.
| BSE: 506820 | Sector: Health care |
| NSE: ASTRAZEN | ISIN Code: INE203A01020 |
| BSE 09:40 | 09 Feb | 3327.05 |
-5.95 (-0.18%) |
OPEN
3327.05 |
HIGH
3327.05 |
LOW
3327.05 |
| NSE 09:29 | 09 Feb | 3342.65 |
9.20 (0.28%) |
OPEN
3349.85 |
HIGH
3349.85 |
LOW
3327.95 |
| OPEN | 3327.05 |
| PREVIOUS CLOSE | 3333.00 |
| VOLUME | 10 |
| 52-Week high | 3619.70 |
| 52-Week low | 2437.75 |
| P/E | 90.29 |
| Mkt Cap.(Rs cr) | 8,318 |
| Buy Price | 3326.20 |
| Buy Qty | 9.00 |
| Sell Price | 3329.15 |
| Sell Qty | 3.00 |
Astrazeneca Pharma India Ltd. (ASTRAZEN) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 1014.55 | 0.11 | 1071.90 | 789.75 | 243420.97 |
| Cipla | 1035.65 | -0.35 | 1185.20 | 880.00 | 83592.49 |
| Divi's Lab. | 2835.15 | 1.24 | 4640.95 | 2740.10 | 75259.06 |
| Dr Reddy's Labs | 4519.00 | 0.73 | 4645.55 | 3655.00 | 75250.39 |
| Apollo Hospitals | 4337.45 | -1.13 | 5015.45 | 3365.90 | 62363.86 |
| Torrent Pharma. | 1560.95 | 0.29 | 1722.70 | 1242.50 | 52828.79 |
| Zydus Lifesci. | 478.90 | 1.00 | 482.20 | 319.40 | 48474.26 |
| Abbott India | 21494.90 | 1.06 | 22481.80 | 15526.50 | 45676.66 |
| Max Healthcare | 439.15 | 0.31 | 482.50 | 306.00 | 42635.32 |
| Alkem Lab | 3222.80 | 1.41 | 3720.00 | 2835.00 | 38528.57 |
| Lupin | 775.65 | 0.05 | 812.30 | 583.05 | 35284.32 |
| Biocon | 244.40 | 0.06 | 410.50 | 229.70 | 29342.66 |
| Aurobindo Pharma | 449.40 | 0.97 | 730.00 | 397.30 | 26330.35 |
| Syngene Intl. | 570.35 | 1.62 | 682.25 | 508.10 | 22895.56 |
| Ipca Labs. | 884.90 | 2.11 | 1089.00 | 830.00 | 22449.91 |
| Gland Pharma | 1341.55 | -0.13 | 3596.70 | 1169.75 | 22095.33 |
| Glaxosmi. Pharma | 1283.40 | 0.35 | 1734.90 | 1230.70 | 21742.08 |
| Fortis Health. | 279.40 | -0.13 | 324.80 | 219.80 | 21093.58 |
| Laurus Labs | 340.40 | 0.55 | 626.00 | 324.25 | 18335.65 |
| Pfizer | 3870.15 | 0.27 | 4662.35 | 3768.00 | 17705.94 |
Quick Links for Astrazeneca Pharma India:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
